{
  "DOI": "10.1186/s40246-023-00496-2",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00496-2",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eThe use of molecular biomarkers for COVID-19 remains unconclusive. The application of a molecular biomarker in combination with clinical ones that could help classifying aggressive patients in first steps of the disease could help clinician and sanitary system a better management of the disease. Here we characterize the role of \u003cjats:italic\u003eACE2, AR, MX1, ERG, ETV5\u003c/jats:italic\u003e and \u003cjats:italic\u003eTMPRSS2\u003c/jats:italic\u003e for trying a better classification of COVID-19 through knowledge of the disease mechanisms.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eA total of 329 blood samples were genotyped in \u003cjats:italic\u003eACE2\u003c/jats:italic\u003e, \u003cjats:italic\u003eMX1\u003c/jats:italic\u003e and \u003cjats:italic\u003eTMPRSS2\u003c/jats:italic\u003e. RNA analyses were also performed from 258 available samples using quantitative polymerase chain reaction for genes: \u003cjats:italic\u003eERG, ETV5, AR, MX1, ACE2,\u003c/jats:italic\u003e and \u003cjats:italic\u003eTMPRSS2.\u003c/jats:italic\u003e Moreover, in silico analysis variant effect predictor, ClinVar, IPA, DAVID, GTEx, STRING and miRDB database was also performed. Clinical and demographic data were recruited from all participants following WHO classification criteria.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eWe confirm the use of ferritin (\u003cjats:italic\u003ep\u003c/jats:italic\u003e \u0026lt; 0.001), D-dimer (\u003cjats:italic\u003ep\u003c/jats:italic\u003e \u0026lt; 0.010), CRP (\u003cjats:italic\u003ep\u003c/jats:italic\u003e \u0026lt; 0.001) and LDH (\u003cjats:italic\u003ep\u003c/jats:italic\u003e \u0026lt; 0.001) as markers for distinguishing mild and severe cohorts. Expression studies showed that \u003cjats:italic\u003eMX1\u003c/jats:italic\u003e and \u003cjats:italic\u003eAR\u003c/jats:italic\u003e are significantly higher expressed in mild vs severe patients (\u003cjats:italic\u003ep\u003c/jats:italic\u003e \u0026lt; 0.05). \u003cjats:italic\u003eACE2\u003c/jats:italic\u003e and \u003cjats:italic\u003eTMPRSS2\u003c/jats:italic\u003e are involved in the same molecular process of membrane fusion (\u003cjats:italic\u003ep\u003c/jats:italic\u003e = 4.4 × 10\u003cjats:sup\u003e–3\u003c/jats:sup\u003e), acting as proteases (\u003cjats:italic\u003ep\u003c/jats:italic\u003e = 0.047).\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eIn addition to the key role of \u003cjats:italic\u003eTMPSRSS2\u003c/jats:italic\u003e, we reported for the first time that higher expression levels of \u003cjats:italic\u003eAR\u003c/jats:italic\u003e are related with a decreased risk of severe COVID-19 disease in females. Moreover, functional analysis demonstrates that \u003cjats:italic\u003eACE2, MX1\u003c/jats:italic\u003e and \u003cjats:italic\u003eTMPRSS2\u003c/jats:italic\u003e are relevant markers in this disease.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eGraphical abstract\u003c/jats:title\u003e\n                \n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "496"
  ],
  "article-number": "50",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "18 April 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "30 May 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "7 June 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The study protocol was approved by the Ethics Committee (CEI) with internal code 1329-N-21. Informed written consent from all participants was obtained in accordance with the tenets of the Declaration of Helsinki."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The author declare no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Martinez-Diz",
      "given": "Silvia",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Morales-Álvarez",
      "given": "Carmen Maria",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Garcia-Iglesias",
      "given": "Yarmila",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guerrero-González",
      "given": "Juan Miguel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Romero-Cachinero",
      "given": "Catalina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "González-Cabezuelo",
      "given": "Jose María",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Fernandez-Rosado",
      "given": "Francisco Javier",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Arenas-Rodríguez",
      "given": "Verónica",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lopez-Cintas",
      "given": "Rocío",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Alvarez-Cubero",
      "given": "Maria Jesús",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Martinez-Gonzalez",
      "given": "Luis Javier",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        6,
        7
      ]
    ],
    "date-time": "2023-06-07T09:02:02Z",
    "timestamp": 1686128522000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        6,
        7
      ]
    ],
    "date-time": "2023-06-07T09:08:25Z",
    "timestamp": 1686128905000
  },
  "funder": [
    {
      "DOI": "10.13039/501100010566",
      "award": [
        "PECOVID-0006-2020",
        "PECOVID-0006-2020"
      ],
      "doi-asserted-by": "publisher",
      "name": "Consejería de Salud y Familias, Junta de Andalucía"
    },
    {
      "award": [
        "CV20-36740",
        "CV20-36740"
      ],
      "name": "Secretaria General Universidades, Investigación y Tecnología, Junta de Andalucia"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        6,
        8
      ]
    ],
    "date-time": "2023-06-08T04:44:23Z",
    "timestamp": 1686199463668
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        6,
        7
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            6,
            7
          ]
        ],
        "date-time": "2023-06-07T00:00:00Z",
        "timestamp": 1686096000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            6,
            7
          ]
        ],
        "date-time": "2023-06-07T00:00:00Z",
        "timestamp": 1686096000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00496-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00496-2/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00496-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        6,
        7
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        6,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3389/fgene.2021.667231",
      "author": "K Schönfelder",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Genet",
      "key": "496_CR1",
      "unstructured": "Schönfelder K, Breuckmann K, Elsner C, Dittmer U, Fistera D, Herbstreit F, et al. Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: a German Case-Control Study. Front Genet. 2021;12: 667231.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1073/pnas.2002589117",
      "author": "S Matsuyama",
      "doi-asserted-by": "publisher",
      "first-page": "7001",
      "issue": "13",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "496_CR2",
      "unstructured": "Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020;117(13):7001–3.",
      "volume": "117",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s12041-021-01262-w",
      "author": "S Senapati",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "J Genet",
      "key": "496_CR3",
      "unstructured": "Senapati S, Banerjee P, Bhagavatula S, Kushwaha PP, Kumar S. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19. J Genet. 2021;100:1–6.",
      "volume": "100",
      "year": "2021"
    },
    {
      "DOI": "10.3390/vaccines11020204",
      "author": "R Nejat",
      "doi-asserted-by": "publisher",
      "first-page": "204",
      "issue": "2",
      "journal-title": "Vaccines (Basel)",
      "key": "496_CR4",
      "unstructured": "Nejat R, Torshizi MF, Najafi DJ. S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review. Vaccines (Basel). 2023;11(2):204.",
      "volume": "11",
      "year": "2023"
    },
    {
      "DOI": "10.1016/j.isci.2020.101585",
      "author": "J Bizzotto",
      "doi-asserted-by": "publisher",
      "first-page": "101585",
      "issue": "10",
      "journal-title": "iScience",
      "key": "496_CR5",
      "unstructured": "Bizzotto J, Sanchis P, Abbate M, Lage-Vickers S, Lavignolle R, Toro A, et al. SARS-CoV-2 infection boosts MX1 antiviral effector in COVID-19 patients. iScience. 2020;23(10):101585.",
      "volume": "23",
      "year": "2020"
    },
    {
      "DOI": "10.7754/Clin.Lab.2022.220104",
      "doi-asserted-by": "crossref",
      "key": "496_CR6",
      "unstructured": "Ghoreshi Z, Abbasi-Jorjandi M, Asadikaram G, Sharifzak M, Rezazadeh-Jabalbarzi M, Rashidinejad H. Evaluation of MX1 gene promoter methylation in different severities of COVID-19 considering patient gender. Clin Lab 2022;68(10)."
    },
    {
      "DOI": "10.1210/endocr/bqab114",
      "author": "F Mauvais-Jarvis",
      "doi-asserted-by": "publisher",
      "first-page": "bqab114",
      "issue": "8",
      "journal-title": "Endocrinology",
      "key": "496_CR7",
      "unstructured": "Mauvais-Jarvis F. Do anti-androgens have potential as therapeutics for COVID-19? Endocrinology. 2021;162(8):bqab114.",
      "volume": "162",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.ejphar.2021.173922",
      "author": "K Baby",
      "doi-asserted-by": "publisher",
      "first-page": "173922",
      "journal-title": "Eur J Pharmacol",
      "key": "496_CR8",
      "unstructured": "Baby K, Maity S, Mehta CH, Suresh A, Nayak UY, Nayak Y. SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: an in silico drug repurposing study. Eur J Pharmacol. 2021;896:173922.",
      "volume": "896",
      "year": "2021"
    },
    {
      "DOI": "10.1080/07391102.2020.1835726",
      "author": "GA Gyebi",
      "doi-asserted-by": "publisher",
      "first-page": "2121",
      "issue": "5",
      "journal-title": "J Biomol Struct Dyn",
      "key": "496_CR9",
      "unstructured": "Gyebi GA, Adegunloye AP, Ibrahim IM, Ogunyemi OM, Afolabi SO, Ogunro OB. Prevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2. J Biomol Struct Dyn. 2022;40(5):2121–45.",
      "volume": "40",
      "year": "2022"
    },
    {
      "DOI": "10.1111/jocd.13443",
      "author": "A Goren",
      "doi-asserted-by": "publisher",
      "first-page": "1545",
      "issue": "7",
      "journal-title": "J Cosmet Dermatol",
      "key": "496_CR10",
      "unstructured": "Goren A, Vaño-Galván S, Wambier CG, McCoy J, Gomez-Zubiaur A, Moreno-Arrones OM, et al. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain: a potential clue to the role of androgens in COVID-19 severity. J Cosmet Dermatol. 2020;19(7):1545–7.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s11481-020-09974-z",
      "author": "S Mukherjee",
      "doi-asserted-by": "publisher",
      "first-page": "38",
      "issue": "1",
      "journal-title": "J Neuroimmune Pharmacol",
      "key": "496_CR11",
      "unstructured": "Mukherjee S, Pahan K. Is COVID-19 Gender-sensitive? J Neuroimmune Pharmacol. 2021;16(1):38–47.",
      "volume": "16",
      "year": "2021"
    },
    {
      "DOI": "10.1002/jcph.1641",
      "author": "JD Strope",
      "doi-asserted-by": "publisher",
      "first-page": "801",
      "issue": "7",
      "journal-title": "J Clin Pharmacol",
      "key": "496_CR12",
      "unstructured": "Strope JD, PharmD CHC, Figg WD. TMPRSS2: potential biomarker for COVID-19 outcomes. J Clin Pharmacol. 2020;60(7):801–7.",
      "volume": "60",
      "year": "2020"
    },
    {
      "DOI": "10.1080/14787210.2023.2179035",
      "author": "A Ahmad",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "issue": "3",
      "journal-title": "Expert Rev Anti Infect Ther",
      "key": "496_CR13",
      "unstructured": "Ahmad A, Makhmutova Z, Cao W, Majaz S, Amin A, Xie Y. Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach. Expert Rev Anti Infect Ther. 2023;21(3):317–27.",
      "volume": "21",
      "year": "2023"
    },
    {
      "DOI": "10.1038/s41390-022-02163-z",
      "doi-asserted-by": "crossref",
      "key": "496_CR14",
      "unstructured": "Silva MG, Falcoff NL, Corradi GR, Di Camillo N, Seguel RF, Tabaj GC, et al. Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels. Pediatric Res 2022:1–5."
    },
    {
      "DOI": "10.3390/v15020271",
      "author": "K Metzdorf",
      "doi-asserted-by": "publisher",
      "first-page": "271",
      "issue": "2",
      "journal-title": "Viruses",
      "key": "496_CR15",
      "unstructured": "Metzdorf K, Jacobsen H, Greweling-Pils MC, Hoffmann M, Lüddecke T, Miller F, et al. TMPRSS2 is essential for SARS-CoV-2 beta and omicron infection. Viruses. 2023;15(2):271.",
      "volume": "15",
      "year": "2023"
    },
    {
      "DOI": "10.3390/cells11121978",
      "doi-asserted-by": "crossref",
      "key": "496_CR16",
      "unstructured": "Niedźwiedzka-Rystwej P, Majchrzak A, Aksak-Wąs B, Serwin K, Czajkowski Z, Grywalska E, et al. Programmed cell death-1/programmed cell death-1 ligand as prognostic markers of coronavirus disease 2019 severity. Cells 2022;11(12)."
    },
    {
      "DOI": "10.7150/ijms.75337",
      "author": "G Savic",
      "doi-asserted-by": "publisher",
      "first-page": "1903",
      "issue": "13",
      "journal-title": "Int J Med Sci",
      "key": "496_CR17",
      "unstructured": "Savic G, Stevanovic I, Mihajlovic D, Jurisevic M, Gajovic N, Jovanovic I, et al. MMP-9/BDNF ratio predicts more severe COVID-19 outcomes. Int J Med Sci. 2022;19(13):1903–11.",
      "volume": "19",
      "year": "2022"
    },
    {
      "DOI": "10.1002/eji.202249827",
      "doi-asserted-by": "crossref",
      "key": "496_CR18",
      "unstructured": "Schrijver IT, Théroude C, Antonakos N, Regina J, Le Roy D, Bart P, et al. COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions. Eur J Immunol 2022."
    },
    {
      "DOI": "10.1016/j.isci.2021.102823",
      "author": "JS Maras",
      "doi-asserted-by": "publisher",
      "first-page": "102823",
      "issue": "8",
      "journal-title": "iScience",
      "key": "496_CR19",
      "unstructured": "Maras JS, Sharma S, Bhat A, Rooge S, Aggrawal R, Gupta E, et al. Multi-omics analysis of respiratory specimen characterizes baseline molecular determinants associated with SARS-CoV-2 outcome. iScience. 2021;24(8):102823.",
      "volume": "24",
      "year": "2021"
    },
    {
      "DOI": "10.1124/jpet.122.001209",
      "doi-asserted-by": "crossref",
      "key": "496_CR20",
      "unstructured": "Gambardella J, Kansakar U, Sardu C, Messina V, Jankauskas SS, Marfella R, et al. Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19. J Pharmacol Exp Ther 2022."
    },
    {
      "key": "496_CR21",
      "unstructured": "Hu R-, Liu C, Yan Y-, Li D. Identification of hub genes and molecular subtypes in COVID-19 based on WGCNA. Eur Rev Med Pharmacol Sci 2021 -10;25(20):6411–6424."
    },
    {
      "DOI": "10.1016/j.bbrc.2020.05.179",
      "author": "LM Irham",
      "doi-asserted-by": "publisher",
      "first-page": "263",
      "issue": "2",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "496_CR22",
      "unstructured": "Irham LM, Chou W, Calkins MJ, Adikusuma W, Hsieh S, Chang W. Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents. Biochem Biophys Res Commun. 2020;529(2):263–9.",
      "volume": "529",
      "year": "2020"
    },
    {
      "DOI": "10.1155/2022/1806427",
      "author": "L Che",
      "doi-asserted-by": "publisher",
      "first-page": "1806427",
      "journal-title": "Biomed Res Int",
      "key": "496_CR23",
      "unstructured": "Che L, Chen G, Cai X, Xie Z, Xia T, Zhang W, et al. Bioinformatics approach predicts candidate targets for SARS-CoV-2 infections to COPD patients. Biomed Res Int. 2022;2022:1806427.",
      "volume": "2022",
      "year": "2022"
    },
    {
      "DOI": "10.3389/fgene.2020.564741",
      "doi-asserted-by": "crossref",
      "key": "496_CR24",
      "unstructured": "Srivastava A, Bandopadhyay A, Das D, Pandey RK, Singh V, Khanam N, et al. Genetic Association of ACE2 rs2285666 Polymorphism With COVID-19 Spatial Distribution in India. Front Genet 2020;0."
    },
    {
      "DOI": "10.1016/j.isci.2022.104614",
      "author": "D Richard",
      "doi-asserted-by": "publisher",
      "first-page": "104614",
      "issue": "7",
      "journal-title": "iScience",
      "key": "496_CR25",
      "unstructured": "Richard D, Muthuirulan P, Aguiar J, Doxey AC, Banerjee A, Mossman K, et al. Intronic regulation of SARS-CoV-2 receptor (ACE2) expression mediated by immune signaling and oxidative stress pathways. iScience. 2022;25(7):104614.",
      "volume": "25",
      "year": "2022"
    },
    {
      "DOI": "10.1186/s12985-022-01782-6",
      "author": "N Alimoradi",
      "doi-asserted-by": "publisher",
      "first-page": "48",
      "issue": "1",
      "journal-title": "Virol J",
      "key": "496_CR26",
      "unstructured": "Alimoradi N, Sharqi M, Firouzabadi D, Sadeghi MM, Moezzi MI, Firouzabadi N. SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease. Virol J. 2022;19(1):48.",
      "volume": "19",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41598-022-15898-w",
      "author": "A Samy",
      "doi-asserted-by": "publisher",
      "first-page": "11934",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "496_CR27",
      "unstructured": "Samy A, Maher MA, Abdelsalam NA, Badr E. SARS-CoV-2 potential drugs, drug targets, and biomarkers: a viral-host interaction network-based analysis. Sci Rep. 2022;12(1):11934.",
      "volume": "12",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.omtn.2022.06.006",
      "author": "M Calderon-Dominguez",
      "doi-asserted-by": "publisher",
      "first-page": "76",
      "journal-title": "Mol Ther Nucleic Acids",
      "key": "496_CR28",
      "unstructured": "Calderon-Dominguez M, Trejo-Gutierrez E, González-Rovira A, Beltrán-Camacho L, Rojas-Torres M, Eslava-Alcón S, et al. Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients. Mol Ther Nucleic Acids. 2022;29:76–87.",
      "volume": "29",
      "year": "2022"
    },
    {
      "DOI": "10.1093/bioinformatics/btt703",
      "author": "A Krämer",
      "doi-asserted-by": "publisher",
      "first-page": "523",
      "issue": "4",
      "journal-title": "Bioinformatics",
      "key": "496_CR29",
      "unstructured": "Krämer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30(4):523–30.",
      "volume": "30",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.compbiomed.2021.104570",
      "author": "B Banaganapalli",
      "doi-asserted-by": "publisher",
      "first-page": "104570",
      "journal-title": "Comput Biol Med",
      "key": "496_CR30",
      "unstructured": "Banaganapalli B, Al-Rayes N, Awan ZA, Alsulaimany FA, Alamri AS, Elango R, et al. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection. Comput Biol Med. 2021;135:104570.",
      "volume": "135",
      "year": "2021"
    },
    {
      "DOI": "10.4103/jfmpc.jfmpc_941_21",
      "author": "A Sana",
      "doi-asserted-by": "publisher",
      "first-page": "260",
      "issue": "1",
      "journal-title": "J Family Med Primary Care",
      "key": "496_CR31",
      "unstructured": "Sana A, Avneesh M. Identification of hematological and inflammatory parameters associated with disease severity in hospitalized patients of COVID-19. J Family Med Primary Care. 2022;11(1):260–4.",
      "volume": "11",
      "year": "2022"
    },
    {
      "DOI": "10.1186/s12879-022-07520-1",
      "author": "H Ashktorab",
      "doi-asserted-by": "publisher",
      "first-page": "552",
      "issue": "1",
      "journal-title": "BMC Infect Dis",
      "key": "496_CR32",
      "unstructured": "Ashktorab H, Pizuorno A, Adeleye F, Laiyemo A, Dalivand MM, Aduli F, et al. Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans. BMC Infect Dis. 2022;22(1):552.",
      "volume": "22",
      "year": "2022"
    },
    {
      "DOI": "10.1080/21645515.2022.2094653",
      "doi-asserted-by": "crossref",
      "key": "496_CR33",
      "unstructured": "Stefanizzi P, Tafuri S, Bianchi FP. Immunogenicity of third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: An open question. Hum Vaccin Immunother 2022:2094653."
    },
    {
      "DOI": "10.15557/PiMR.2020.0003",
      "doi-asserted-by": "crossref",
      "key": "496_CR34",
      "unstructured": "World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance. Geneva: March 2020. Available at: https://apps.who.int/iris/handle/10665/331446."
    },
    {
      "DOI": "10.1186/s13059-016-0974-4",
      "author": "W McLaren",
      "doi-asserted-by": "publisher",
      "first-page": "122",
      "issue": "1",
      "journal-title": "Genome Biol",
      "key": "496_CR35",
      "unstructured": "McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The ensembl variant effect predictor. Genome Biol. 2016;17(1):122.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1093/nar/gkaa1074",
      "author": "D Szklarczyk",
      "doi-asserted-by": "publisher",
      "first-page": "D605",
      "issue": "D1",
      "journal-title": "Nucleic Acids Res",
      "key": "496_CR36",
      "unstructured": "Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–12.",
      "volume": "49",
      "year": "2021"
    },
    {
      "DOI": "10.1093/nar/gkaa467",
      "author": "L Chang",
      "doi-asserted-by": "publisher",
      "first-page": "W244",
      "issue": "W1",
      "journal-title": "Nucleic Acids Res",
      "key": "496_CR37",
      "unstructured": "Chang L, Zhou G, Soufan O, Xia J. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 2020;48(W1):W244–51.",
      "volume": "48",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12859-017-1990-4",
      "doi-asserted-by": "crossref",
      "key": "496_CR38",
      "unstructured": "Martorell-Marugan J, Toro-Dominguez D, Alarcon-Riquelme ME, Carmona-Saez P.  MetaGenyo: a web tool for meta-analysis of genetic association studies. BMC Bioinformatics 2017;18(1):563."
    }
  ],
  "reference-count": 38,
  "references-count": 38,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00496-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}